Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This combination is a specialized oral rehydration solution (ORS) designed to enhance fluid absorption and systemic fluid retention. Glycerol acts as an osmotic agent that promotes a state of hyperhydration by increasing the osmotic pressure of body fluids, which in turn reduces free water clearance by the kidneys. The carbohydrate component, typically glucose or maltodextrin, facilitates the active transport of sodium and water across the intestinal epithelium via the sodium-glucose cotransporter 1 (SGLT1). The electrolytes, including sodium, potassium, chloride, and citrate, replace essential ions lost during dehydration and maintain plasma volume. This solution is primarily used for the prevention and treatment of dehydration, particularly in scenarios where prolonged fluid retention is beneficial, such as in sports medicine, heat-related illness, or perioperative fluid management.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on glycerol + carbohydrate + electrolyte solution.